中国循证医学杂志

中国循证医学杂志

醒脑静注射液治疗脑出血的系统评价

查看全文

目的 系统评价醒脑静注射液能否改善脑出血患者的功能性结局及导致不良反应。
方法 通过计算机检索、手工检索及向药厂索取资料,全面收集全世界范围内醒脑静注射液治疗脑出血的随机对照试验(RCT),并按 Cochrane 协作网推荐的方法进行系统评价。
结果 共纳入 13 个 RCT(1 035 例患者),其中 3 个试验报告了死亡或依赖人数, 11 个试验在治疗末进行了神经功能缺损评价,所有试验均未观察到严重不良反应。Meta 分析结果显示,① 死亡 / 依赖: 3 个试验(204 例患者)于随访结束后对患者的日常生活能力进行了评价,醒脑静注射液治疗组与对照组比较有减少患者死亡/依赖的趋势,但差异无统计学意义 [Peto-OR=0.57, 95%CI(0.32, 1.01)]。② 不良反应:未观察到严重不良反应。③ 神经功能缺损程度: 11 个试验(915 例患者)在治疗末进行了神经功能缺损程度的评价,醒脑静注射液治疗组与对照组比较能显著改善神经功能缺损,差异有统计学意义[Peto-OR=3.70, 95%CI(2.67, 5.13) ]。
结论 现有的临床研究证据显示,与对照组比较,醒脑静注射液有减少脑出血患者的死亡/ 依赖的趋势,能改善患者的神经功能缺损,但因研究质量及研究样本的局限性,尚需进行高质量、大样本的随机对照试验予以进一步证实。

Objective To determine whether Xingnaojing injection can improve functional outcome without causing harm in patients with intracerebral hemorrhage.
Methods We searched the electronic bibl iographic databases: Cochrane Central Register of Controlled Trials(CENTRAL, Issue 3, 2007), MEDLINE (1996 to November 2007),EMBASE (1984 to November 2007) and China Biological Medicine Database (1978 to November 2007). We also did handsearching to identify other publ ished and unpubl ished data. Data were extracted and evaluated by two reviewers independently with a designed extraction form. The Cochrane Collaboration’s RevMan 4.2.10 was used for data analysis.
Results Thirteen randomized trials involving 1 035 patients were included. The number of people who had died or were dependent at the end of long-term follow-up (at least 3 months) were reported in three trials. Eleven trials measured neurological deficit at the end of treatment. No severe adverse events were reported. The results of meta-analyses indicated that Xingnaojing injection might decrease the number of death or dependency compared to the control group, but the difference was not statistically significant (Peto-OR 0.57, 95%CI 0.32 to 1.01); and Xingnaojing injection were associated with a significant improvement in neurological deficit (Peto-OR 3.70, 95%CI 2.67 to 5.13).
Conclusion The evidence currently available showed that Xingnaojing injection may decrease the risk of death or dependency, and can also reduce neurological deficit in patients with intracerebral hemorrhage. However, more high-qual ity trials are needed.

关键词: 醒脑静注射液; 脑出血; 随机对照试验; 系统评价; Meta分析

Key words: Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China

引用本文: 林森,吴波,刘鸣. 醒脑静注射液治疗脑出血的系统评价. 中国循证医学杂志, 2008, 08(2): 93-96. doi: 10.7507/1672-2531.20080024 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurology, 2007, 6: 456-464.
2. 罗侃, 刘苏中, 徐润, 等. 临床应用醒脑静注射液的综合总结. 中国中西医急症, 1997, 6(3): 119.
3. 梁黔生, 杨光田, 郑智. 醒脑静治疗镇静催眠药中毒的临床观察. 中国急救医学, 1999, 19(12): 742.
4. 各类脑血管疾病诊断要点(1995年中华医学会全国第四届脑血管病学术会议通过). 中华神经科杂志, 1996, 29(6): 379.
5. 刘鸣, 张世洪. 临床试验中的意向处理分析. 英国医学杂志(中文版), 2001, 4(4): 223-224.
6. Clarke M, Oxman AD, editors. Cochrane Reviewers,Handbook4.1 [updated June 2000]. In: Review Manager (RevMan) [Computer program] . Version 4.1. Oxford,England:The Cochrane Collaboration, 2000.
7. 叶国强. 醒脑静治疗脑出血70例疗效观察. 实用神经疾病杂志, 2005, 8(1): 60-61.
8. 周丹, 温兴艳, 刘全国. 醒脑静注射液治疗高血压性中小量脑出血疗效观察. 吉林中医药, 2005, 25(6): 35-36.
9. 郑立学, 张卫华. 醒脑静注射液治疗急性重型脑出血临床疗效观察. 中国中西医结合急救杂志, 2001, 8(5): 286.
10. 周义杰. 醒脑静注射液治疗脑出血的临床观察. 河北医学, 2000,6(1): 57-58.
11. 吕晓洲, 韩旭艳, 乔敬华. 醒脑静注射液治疗脑出血疗效观察. 辽宁中医杂志, 2004, 31(10): 851.
12. 丁训艳, 张楠. 醒脑静注射液治疗急性脑出血疗效观察. 现代中西医结合杂志, 2006, 15(21): 2918.
13. 朱勤, 车渝. 醒脑静治疗高血压性脑出血26例. 现代医药卫生, 2005, 21(16): 2158-2159.
14. 童海光, 柯将琼, 甘世旭, 等. 醒脑静注射液辅佐血肿清除术治疗高血压性脑出血的临床观察. 浙江实用医学, 2006, 11(6): 389-390, 392.
15. 吴楚君, 韩景光. 微创穿刺颅内血肿粉碎术合用醒脑静注射液治疗高血压脑出血. 中国临床医生, 2004, 32(3): 31-33.
16. 秦卓红, 郭志鉴, 原培芳. 颅内血肿微创清除术合用醒脑静及复方丹参注射液治疗中重度高血压脑出血. 中西医结合心脑血管病杂志, 2006, 4(12): 1116-1117.
17. 郝清华, 杨苗. 醒脑静注射液对重型脑出血41例的治疗作用. 河南实用神经疾病杂志, 2003, 6(2): 80-81.
18. 扈林, 张燕. 醒脑静注射液对脑出血后脑水肿的影响及临床疗效. 中国医师进修杂志, 2007, 30(1A): 60-61.
19. 黄勉. 醒脑静注射液治疗急性脑出血的临床观察. 中国现代医药杂志, 2006, 8(7): 75-76.
20. 孟家眉. 对脑卒中临床研究工作的建议(1988年全国第二次脑血管病学术会议通过). 中华神经精神科杂志, 1988, (1): 57-59.
21. 陈清棠. 脑卒中患者临床神经功能缺损程度评分标准(1995)(全国第四届脑血管病学术会议通过). 中华神经科杂志, 1996, 29(6): 381-383.
22. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 1995, 273(5): 408-412.